loadpatents
name:-0.012929916381836
name:-0.0056629180908203
name:-0.0061140060424805
Suri; Anish Patent Filings

Suri; Anish

Patent Applications and Registrations

Patent applications and USPTO patent grants for Suri; Anish.The latest application filed is for "antibody polypeptides that antagonize cd40l".

Company Profile
7.12.16
  • Suri; Anish - Beerse BE
  • SURI; Anish - Ekeren BE
  • Suri; Anish - Cambridge MA
  • Suri; Anish - Yardley PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Nucleic acids encoding anti-CD154 antibodies
Grant 11,421,037 - Fransson , et al. August 23, 2
2022-08-23
Antibody Polypeptides That Antagonize Cd40l
App 20220073636 - NADLER; Steven G. ;   et al.
2022-03-10
Multimeric T-cell Modulatory Polypeptides And Methods Of Use Thereof
App 20220017596 - Cemerski; Saso ;   et al.
2022-01-20
Antibody polypeptides that antagonize CD40L
Grant 11,180,567 - Nadler , et al. November 23, 2
2021-11-23
Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40
Grant 11,136,406 - Suri , et al. October 5, 2
2021-10-05
Anti-cd154 Antibodies And Methods Of Using Them
App 20200317794 - Fransson; Johan ;   et al.
2020-10-08
Methods Of Treating Transplant Rejection Using A Domain Antibody Directed Against Cd40l
App 20200231676 - SURI; Anish ;   et al.
2020-07-23
Methods Of Treating Immune Diseases By Administering Antibody Polypeptides That Antagonize Cd40
App 20200199244 - SURI; Anish ;   et al.
2020-06-25
Anti-CD154 antibodies and methods of using them
Grant 10,669,343 - Fransson , et al.
2020-06-02
Nucleic acids encoding antibody polypeptides that antagonize CD40
Grant 10,544,228 - Suri , et al. Ja
2020-01-28
Antibody Polypeptides That Antagonize Cd40l
App 20190100595 - NADLER; Steven G. ;   et al.
2019-04-04
Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40L
Grant 10,196,451 - Nadler , et al. Fe
2019-02-05
Antibody Polypeptides That Antagonize Cd40l
App 20180051091 - NADLER; Steven G. ;   et al.
2018-02-22
Antibody polypeptides that antagonize CD40L
Grant 9,765,150 - Nadler , et al. September 19, 2
2017-09-19
Methods Of Treating Transplant Rejection Using A Domain Antibody Directed Against Cd40
App 20170051059 - SURI; Anish ;   et al.
2017-02-23
Anti-CD154 antibodies and methods of using them
App 20170037136 - Fransson; Johan ;   et al.
2017-02-09
Antibody Polypeptides That Antagonize Cd40
App 20170015754 - SURI; Anish ;   et al.
2017-01-19
Antibody polypeptides that antagonize CD40
Grant 9,475,879 - Suri , et al. October 25, 2
2016-10-25
Antibody Polypeptides That Antagonize Cd40l
App 20160075790 - NADLER; Steven G. ;   et al.
2016-03-17
Antibody polypeptides that antagonize CD40L
Grant 9,228,018 - Nadler , et al. January 5, 2
2016-01-05
Nucleic acids encoding antibody polypeptides that antagonize CD40L
Grant 8,981,072 - Nadler , et al. March 17, 2
2015-03-17
Antibody Polypeptides That Antagonize Cd40l
App 20150023976 - NADLER; Steven G. ;   et al.
2015-01-22
Antibody polypeptides that antagonize CD40L
Grant 8,895,010 - Nadler , et al. November 25, 2
2014-11-25
Antibody Polypeptides That Antagonize Cd40l
App 20140099707 - NADLER; Steven G. ;   et al.
2014-04-10
Antibody Polypeptides That Antagonize Cd40
App 20140099317 - Suri; Anish ;   et al.
2014-04-10
Antibody Polypeptides That Antagonize Cd40l
App 20130095109 - NADLER; Steven G. ;   et al.
2013-04-18
Company Registrations
SEC0001739130Suri Anish

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed